Validation of the ANAM Test Battery in Parkinson's Disease

Abstract

At the completion of one year, there is empirical evidence that the Parkinson's disease (PD) ANAM battery is sensitive to neurocognitive change independently identified by traditional neurocognitive testing. Individuals exhibiting mild neurocognitive impairment demonstrated poorer cognitive efficiency on nine ANAM tasks compared with both normal controls and cognitively- intact PD patients. Moreover, the latter two groups did not differ from one another on ANAM performance. The WI CE, a comprehensive index of cognitive efficiency weighted so that each of eight ANAM tasks contributed equally, demonstrated that the battery as a whole is sensitive to cognitive impairment subsequent to PD. Age-related differences in ANAM performance were identified by the present study. It was also noted that significantly more female PD patients exhibited cognitive decline than men even though the full PD sample had more of the latter.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 2005
Accession Number
ADA452204

Entities

People

  • Karen Anderson
  • Lisa Shulman
  • Paul Short
  • Robert Kane
  • Stephen Reich
  • William Weiner

Organizations

  • University of Baltimore

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Alzheimer Disease
  • Cognition
  • Cognitive Impairment
  • Data Analysis
  • Databases
  • Dementia
  • Diseases And Disorders
  • Efficiency
  • Health Services
  • Information Science
  • Medical Personnel
  • Mental Processes
  • Military Personnel
  • Parkinson'S Disease
  • Psychology
  • Regression Analysis
  • Test And Evaluation

Fields of Study

  • Psychology

Readers

  • Mathematics or Statistics
  • Team-Based Human-Centered Cognitive Task Decision Making and Information Performance.
  • Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.